Literature DB >> 25335666

Applicability of the visceral adiposity index (VAI) in predicting components of metabolic syndrome in young adults.

Jéssica Schuster1, Patrícia Vogel1, Cristiane Eckhardt1, Simone Dal Bosco Morelo1.   

Abstract

INTRODUCTION: Metabolic syndrome (MS) is one of the main risk factors for cardiovascular diseases (CVD) and identifying its components in young adults may constitute an important prevention tool.
OBJECTIVE: Analyzing applicability of the Visceral Adiposity Index (VAI) for predicting components of MS in young adults.
METHODS: Cross-sectional survey with 444 individuals, mean age 25.6±6.5, 77.7% females. We obtained data on weight, height, waist circumference (WC), body fat percentage (BF%), fasting glycemia, triglycerides (TG), total cholesterol (TC), HDL cholesterol (HDL-c), LDL cholesterol (LDL-c), and blood pressure (BP), as well as information on their lifestyles. Body Mass Index (BMI), Waist-to-Height Ratio (WHR) and VAI were calculated. Adiposity measurements were compared to the MS components, and for VAI, we determined the predictive capacity of MS components occurrence and the area below the ROC curve.
RESULTS: VAI correlated to glucose (r=0.136), HDL-c (r=-436), and TG (r=0.825) in females, and amongst men, it correlated to glucose (r=0.258), HDL-c (r=-0.550), TG (r=0.897), and DBP (r=0.290). An increased VAI was associated to an increased risk of abdominal obesity (OR=1.86), hypertriglyceridemia (OR=30.74), and low HDL-c (OR=3.95). Among obesity indicators, VAI presented a larger area below the curve for increased TG and low HDL-c.
CONCLUSION: VAI presented an association to MS components in males and females with an increased risk of abdominal obesity, hipertriglyceridemia, and low HDL-c, proving to be a good MS components predictor even among healthy young adults. Copyright AULA MEDICA EDICIONES 2014. Published by AULA MEDICA. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25335666     DOI: 10.3305/nh.2014.30.4.7644

Source DB:  PubMed          Journal:  Nutr Hosp        ISSN: 0212-1611            Impact factor:   1.057


  12 in total

1.  Giant mice reveal new roles for GH in regulating the adipose immune microenvironment.

Authors:  Angela K Odle; Paul D Drew; Gwen V Childs
Journal:  Endocrinology       Date:  2015-05       Impact factor: 4.736

2.  Abdominal Obesity Is More Strongly Correlated with Obstructive Sleep Apnea than General Obesity in China: Results from Two Separated Observational and Longitudinal Studies.

Authors:  Xiaolong Zhao; Huajun Xu; Yingjun Qian; Yupu Liu; Juanjuan Zou; Hongliang Yi; Jian Guan; Shankai Yin
Journal:  Obes Surg       Date:  2019-08       Impact factor: 4.129

3.  Does FMI Correlate Better than BMI with the Occurrence of Metabolic Changes in Obese Patients? Study Based on 2007 Consecutive Mexican Patients.

Authors:  Carlos A Gutiérrez-Rojas; Ruth Cruz-Soto; Verónica Sánchez-Muñoz; Anayeli Romero; Maureen Mosti-Molina; Hugo A Sánchez-Aguilar; David Velázquez-Fernández; Miguel F Herrera
Journal:  Obes Surg       Date:  2020-04       Impact factor: 4.129

4.  Retrospective study of cardiovascular disease risk factors among a cohort of combat veterans with lower limb amputation.

Authors:  Vibha Bhatnagar; Erin Richard; Ted Melcer; Jay Walker; Michael Galarneau
Journal:  Vasc Health Risk Manag       Date:  2019-09-19

5.  Simple Anthropometric Indices are Useful for Predicting Non-alcoholic Fatty Liver Disease [NAFLD] in Asian Indians.

Authors:  Ayaskanta Singh; Sasmita Parida; Jimmy Narayan; Preetam Nath; Pradeep K Padhi; Girish K Pati; Prasanta K Parida; Chudamani Meher; Omprakash Agrawal; Shivaram P Singh
Journal:  J Clin Exp Hepatol       Date:  2017-05-15

6.  Visceral adiposity index is strongly associated with hyperuricemia independently of metabolic health and obesity phenotypes.

Authors:  Huimin Dong; Yang Xu; Xiuzhi Zhang; Simiao Tian
Journal:  Sci Rep       Date:  2017-08-18       Impact factor: 4.379

7.  Applicability of visceral adiposity index in predicting metabolic syndrome in adults with obstructive sleep apnea: a cross-sectional study.

Authors:  Gong-Ping Chen; Jia-Chao Qi; Bi-Ying Wang; Xin Lin; Xiao-Bin Zhang; Jian-Ming Zhao; Xiao Fang Chen; Ting Lin; Dong-Dong Chen; Qi-Chang Lin
Journal:  BMC Pulm Med       Date:  2016-03-01       Impact factor: 3.317

8.  Percentage of Body Fat and Fat Mass Index as a Screening Tool for Metabolic Syndrome Prediction in Colombian University Students.

Authors:  Robinson Ramírez-Vélez; Jorge Enrique Correa-Bautista; Alejandra Sanders-Tordecilla; Mónica Liliana Ojeda-Pardo; Elisa Andrea Cobo-Mejía; Rocío Del Pilar Castellanos-Vega; Antonio García-Hermoso; Emilio González-Jiménez; Jacqueline Schmidt-RioValle; Katherine González-Ruíz
Journal:  Nutrients       Date:  2017-09-13       Impact factor: 5.717

9.  Three novel obese indicators perform better in monitoring management of metabolic syndrome in type 2 diabetes.

Authors:  Chun-Ming Ma; Na Lu; Rui Wang; Xiao-Li Liu; Qiang Lu; Fu-Zai Yin
Journal:  Sci Rep       Date:  2017-08-29       Impact factor: 4.379

10.  Effect of Gum Arabic (Acacia Senegal) supplementation on visceral adiposity index (VAI) and blood pressure in patients with type 2 diabetes mellitus as indicators of cardiovascular disease (CVD): a randomized and placebo-controlled clinical trial.

Authors:  Rasha Babiker; Khalifa Elmusharaf; Michael B Keogh; Amal M Saeed
Journal:  Lipids Health Dis       Date:  2018-03-20       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.